We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Alveolus, a company focused on development of non-vascular stent technology, has another $15 million in the bank. The Charlotte-based medical device firm, which was launched in 2001, has now raised more than $30 million in three rounds of venture capital.
Covalon Technologies Ltd. announces that the FDA has approved Covalon's proprietary Collagran and Collagran Ag new collagen-based wound dressings for use in the USA.
The MEDICREA Group, specialized in the design, manufacture, and marketing of orthopedic implants for spine surgery, announces the opening of a US subsidiary, MEDICREA USA Corporation.
Devicemakers have expressed concern about cost-containment initiatives by the Centers for Medicare & Medicaid (CMS), and are thought by some experts to be resistant to long-term solutions to controlling healthcare costs.
Kensey Nash Corporation today announced that it has completed enrollment of a pilot trial for its TriActiv ProGuard Embolic Protection System in carotid stenting procedures.
Innocoll, Inc. announced its sales and marketing subsidiary, Innocoll Pharmaceuticals Ltd., has launched a new version of its CollaRx Gentamicin surgical implant that is specially designed for maximum convenience and ease of use in cardiac surgery.